Condition
Community-acquired Pneumonia clinical trials and research
As of November 12, 2026, Find a Trial lists 20 Community-acquired Pneumonia clinical trials that are recruiting, at sites in 41 countries (most in United States (6), France (5), Canada (4)). By phase: Phase 3 (7), Phase 2/3 (1), Phase 4 (1), Phase 2 (1). There are also 14 NIH-funded research projects on Community-acquired Pneumonia, with $7.7 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 20Clinical trials
- 14NIH research projects
- 41Countries
Newest Community-acquired Pneumonia clinical trials
All recruiting trials (20)
-
How frailty affects outcomes in older people with pneumonia in the ER
This study will test whether a quick bedside frailty score (the Clinical Frailty Scale) can help predict short-term death and serious complications in people aged 65 and older who come to the emergency department with pneumonia.
-
Fever clinic tracking of acute respiratory infections
This project follows adults who come to a fever clinic with respiratory infections to see how their symptoms, test results, and outcomes change over time.
-
Azithromycin versus doxycycline as atypical coverage for adults hospitalized with community-acquired pneumonia on a beta-lactam
This trial will test whether adding azithromycin or doxycycline to a beta-lactam works better and is safer for adults hospitalized with community-acquired pneumonia.
-
Noninvasive breathing support for severe community-acquired pneumonia
This trial tests whether high-velocity nasal insufflation (HVNI) or standard noninvasive ventilation (NIV) better helps adults with community-acquired pneumonia and low oxygen levels avoid intubation or death within 48 hours.
-
Antibiotic strategies for young children with pneumonia in outpatient care
This trial will see if a 'watch-and-wait' Safety Net Antibiotic Prescribing (SNAP) approach can safely reduce antibiotic use compared with immediate antibiotics in children aged 12 months to under 6 years with mild community-acquired pneumonia.
-
Awake prone positioning for adults with community-acquired pneumonia on high-flow nasal oxygen.
This trial will test whether asking adults with community-acquired pneumonia who are on high-flow nasal oxygen to lie on their stomach while awake can reduce the need for a breathing tube.
-
Evaluating SR1375 for treating community-acquired pneumonia in adults
This study is testing a new medication called SR1375 to see if it helps adults in the hospital with community-acquired pneumonia feel better and recover safely.
-
Using clarithromycin to prevent sepsis in pneumonia patients
This study is testing if adding clarithromycin to the treatment of pneumonia can help prevent sepsis in patients who are at risk.
-
Comparing Amoxicillin and Amoxicillin/Clavulanate for Pneumonia in Older Adults
This study is testing whether amoxicillin works just as well as a combination of amoxicillin and clavulanate for treating pneumonia in older adults who are hospitalized.
-
Using acyclovir to treat pneumonia in ventilated patients with herpes simplex virus
This study is testing if giving acyclovir to ICU patients on ventilators who have pneumonia and herpes simplex virus can help them survive better than those who don't receive the medication.
-
Improving care for children with pneumonia using new diagnostic tools
This study is testing a new test to see if it can help doctors better treat children with pneumonia by identifying those who don’t need antibiotics, so they can avoid giving unnecessary medication.
-
Comparing two flu vaccines for older adults
This study is testing which of two flu vaccines works better for adults aged 65 and older to prevent the flu and related health issues.
-
Customized antibiotic treatment duration for hospitalized pneumonia patients
This study tests if giving hospitalized pneumonia patients antibiotics for a shorter, personalized time based on their recovery is just as effective as the usual longer treatment.
-
Using heparin to improve outcomes in patients with community-acquired pneumonia
This study is testing whether giving heparin to patients with community-acquired pneumonia can help them avoid complications and recover better than standard care.
-
Evaluating trimodulin for severe community-acquired pneumonia
This study is testing if adding trimodulin to standard treatment can help adults with severe pneumonia who need breathing support feel better and recover faster.
-
Evaluating the prevalence of pneumonia-causing bacteria using a urine test
This study is testing a urine test to see how common pneumonia-causing bacteria are in hospitalized patients with community-acquired pneumonia.
-
Exploring risk factors for poor outcomes in pneumonia patients
This study looks at what factors might lead to worse recovery in adults with pneumonia to help improve their treatment and outcomes.
-
Twice daily amoxicillin treatment for children with non-severe pneumonia
This study is testing if giving children with mild pneumonia amoxicillin twice a day works just as well as giving it three times a day.
-
Evaluating treatments for severe community-acquired pneumonia in ICU patients
This study tests different treatment options for ICU patients with severe pneumonia to see which ones work best, including special strategies for those with COVID-19.
-
Community-acquired pneumonia in adults: who is at risk?
This project collects clinical data and biological samples from adults with community-acquired pneumonia to see which risk factors, causes, and outcomes are linked to the illness.
NIH-funded research (14)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Azithromycin vs doxycycline with beta-lactam in hospitalized adults with pneumonia
In hospitalized adults with community-acquired pneumonia, this study will compare two antibiotic combinations to see which works better and is safer.
-
Combined immunomodulatory effect of macrolides and corticosteroids in hospitalized CAP patients
This study looks at whether adding macrolide antibiotics to steroids helps or harms people hospitalized with community-acquired pneumonia (CAP).
-
Blocking ANGPTL4 to help people with severe community-acquired pneumonia
This project will test whether blocking the blood protein ANGPTL4 helps adults hospitalized with severe community-acquired pneumonia recover faster and survive more often.
-
Pediatric pneumonia severity score (PedCAPS)
This project will create and check a simple score to predict how serious pneumonia will be in children who come to the emergency room.
-
Ketogenic diet to help muscle in older adults with pneumonia
A small trial will test if a short 10-day ketogenic (low carb, high fat) feeding helps preserve muscle and speed recovery in people 65 and older hospitalized with pneumonia.
-
Using systems biology to understand severe community-acquired pneumonia
This project analyzes patients' lung and blood samples with advanced lab tests and computer models to find biological patterns that can help guide treatment for people with severe pneumonia, including COVID-related cases.
-
Targeted antibiotic treatment for community-acquired pneumonia
This project uses faster diagnostic tests to help doctors pick and shorten antibiotics for adults hospitalized with community-acquired pneumonia.
-
Better ways to find pneumonia in children
This project aims to create smarter tools to help doctors quickly and accurately diagnose pneumonia in children who come to the emergency room.
-
Investigating the role of ANGPTL4 in severe pneumonia outcomes
This study is looking at how a protein called ANGPTL4 might influence how well patients with severe pneumonia recover, and it aims to find better ways to help them heal.
-
Creating a score to assess the severity of pneumonia in children
This study is working on a new scoring system to help doctors understand how serious pneumonia is in kids, so they can make better choices about treatment and whether a child needs to stay in the hospital.
-
Modeling severe pneumonia caused by the coronavirus
This study is looking at how severe pneumonia caused by the coronavirus affects patients, using samples from their lungs to find ways to better predict their recovery and improve treatments.
-
Improving diagnosis of pneumonia in children using advanced technology
This study is working on a smart tool to help doctors quickly and accurately diagnose pneumonia in kids using computer data, which could lead to better treatment and less unnecessary medicine.
-
Improving treatment for pneumonia by using targeted therapies
This study is looking at how to better identify the germs that cause community-acquired pneumonia so that patients can get the right antibiotics quickly, helping them recover faster and reducing the chances of antibiotic resistance.
-
Understanding long-term effects of Gram-negative pneumonia
This study is looking at how people who have survived a serious lung infection called pneumonia, caused by a specific germ, do over time after leaving the hospital, and it aims to find out what factors might lead to health problems later on so that doctors can provide better care for those who need it.
Related topics
Quick answers
How many Community-acquired Pneumonia clinical trials are recruiting right now?
20, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 41 countries. The most sites are in United States (6 trials), France (5 trials), Canada (4 trials), Germany (4 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 7, Phase 2/3: 1, Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.